isitlyme said...
Ok, the article i saw mentioned all the deaths without differentiating between placebo and vaccine. Either way, still two deaths on the vaccine group.
This is essentially meaningless when the placebo group has 4 deaths.
isitlyme said...
In Astrazeneca zero, nada, none. On the article you provided says: "FDA denies that the temporary facial paralysis was caused by the shot..". Of course they deny, why would they say it could be a possible cause in susceptible people? It would raise alarm and it would cause people not to take the vaccine, both FDA and PFIZER dont want that. Deaths and facial paralysis = red flags.
Facial paralysis does not equal red flags. I was hoping you would read the entire article... In the headline it says “FDA denys...” but in the body it says “Food and Drug Administration (FDA) regulators said there wasn't any clear way that the vaccine caused Bell's palsy, but warned that doctors should watch for the alarming side effect and Pfizer should continue to keep tab on how many people it strikes.”
“(frequency of bells palsy in the trial) is consistent with the expected background rate in the general population, and there is no clear basis upon which to conclude a causal relationship at this time, but they will keep a close watch on future cases.“
“The four cases of Bell's palsy were the only side effect that the FDA saw as 'imbalanced' with more occurring in the vaccine group than the placebo group”
“As made plain by its name, doctors don't know exactly what causes it.
It can strike at any age, and drag on for weeks, but almost always resolves on its own over weeks or months, so there aren't any particular treatments.
Each year, about
40,000 people in the US develop Bell's palsy.
Put another way, about
one in every 60 to 70 people will suddenly find their face paralyzed at least once over the course of their lifetimes.
There are some patterns to who tends to get Bell's palsy. It's more common in pregnant women, especially during their third trimester, or shortly after birth. People with diabetes are also more prone to Bell's.
Having an upper respiratory infection, like the cold or the flu is also a risk factor.
As a respiratory infection, it's possible that COVID-19 itself could be a risk factor for Bell's palsy. Facial palsy was reported in three Brazilian COVID-19 patients, at least one person in China, a pregnant woman in Portugal, and in a number of Indian patients.”
All cases in the trial resolved. Only one occurred shortly after the shot was given (3 days) and it resolved 3 days after that.
isitlyme said...
On the other hand. Here is the trial results made available by astrazeneca. We read:
"The AstraZeneca and Oxford researchers stressed that there were NO DEATHS], hospitalizations or severe disease observed in the vaccinated groups from three weeks after the first dose. AstraZeneca said the vaccine should exceed regulatory thresholds."
https://www.washingtonpost.com/world/europe/astrazeneca-lancet-covid-vaccine-oxford/2020/12/08/482ca0f0-34b5-11eb-9699-00d311f13d2d_story.html
"from three weeks after the first dose"? Having trouble accessing this article as I’m not a subscriber.
isitlyme said...
Also, in the trial data provided by Astrazeneca, you cannot find even one person who had facial paralysis. Most people had all the common site effects on vaccines, but NOT facial paralysis and of course NO Deaths. Coincidence? Judge it yourself...
Astrazeneca trial data:
https://www.sciencedirect.com/science/article/pii/s0140673620324661?via%3Dihub#fig3
The data made public by Pfizer also did not specifically mention facial paralysis. The FDA released the specifics when it began the review process for Emergency Use Authorization. It very well could be that facial paralysis did occur in the Astrazenca trial as a portion of these "serious adverse events".. from your link:
“As of Oct 26, 2020, 13 serious adverse events have occurred (across all age and vaccine groups), none of which are considered related to either study vaccine as assessed by the investigators”
isitlyme said...
Comparing the two and making a risk/benefit assessment, for me and for now it seems that astrazeneca is more favorable. It doesnt even require the ultra low temps to preserve the vaccine.
It may end up being "more favorable", but it hasn’t received the same level of scrutiny yet.
Post Edited (potsnpans) : 12/11/2020 11:30:42 AM (GMT-7)